Arbutus Biopharma Corporation DSO Ratio 2011-2026 | ABUS

Annual DSO Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50	124	31.5	10.5	36.7	69.3	73.1	112	29.7	170	20.3	61.7	8.71	89	30.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
170	8.71	61.1

Quarterly DSO Ratio Arbutus Biopharma Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
166	9.38	92.9	-	115	103	117	-	46.9	51.8	27.4	-	14.1	4.21	8.02	-	40.5	50.2	55.6	-	78.6	79.1	77	67.9	35.9	168	177	53.5	53.5	74.9	35.6	14.5	5.32	35.3	131	-128	32.2	80.6	96.9	7.25	22.6	26.7	28.4	39.9	39.8	95.9	20.8	14.2	3.6	3.75	25.5	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
177	-128	52.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.63	-2.42 %	$ 8.73 B	Australia
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	99.7	$ 2.14	-1.38 %	$ 445 M	USA
Evogene Ltd. EVGN	30	$ 0.81	-0.07 %	$ 27.9 M	Israel
Amphastar Pharmaceuticals AMPH	70.9	$ 20.47	0.49 %	$ 957 M	USA
Genmab A/S GMAB	97.9	$ 28.2	-0.18 %	$ 18 B	Danmark
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Halozyme Therapeutics HALO	93.4	$ 67.06	-1.12 %	$ 8.04 B	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Harmony Biosciences Holdings HRMY	37.8	$ 28.69	-0.69 %	$ 1.65 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.41	0.71 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.96	1.37 %	$ 4.87 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	103	$ 4.16	1.84 %	$ 445 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.01	-0.85 %	$ 3.05 B	USA
ImmuCell Corporation ICCC	47.5	$ 7.12	1.14 %	$ 64.3 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	321	$ 32.24	-	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	-0.67 %	$ 394 M	Britain
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Incyte Corporation INCY	66.6	$ 94.86	-1.26 %	$ 18.5 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	150	$ 2.61	2.35 %	$ 16.4 M	USA